Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer
暂无分享,去创建一个
J. Schellens | J. Beijnen | G. Sonke | S. Marchetti | M. Mergui-Roelvink | N. Steeghs | E. Harms | R. van der Noll | H. Rehorst